Voltaren Retard 100 mg
Voltaren Retard 100 mg is a medicine authorised by Swissmedic under authorisation number 41962. The authorisation holder is Novartis Pharma Schweiz AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 01 May 1979 and the authorisation is valid without a time limit. ATC code M01AB05 places the medicine in the group Anti-inflammatory and antirheumatic products.
| Authorisation number | 41962 |
|---|---|
| Name | Voltaren Retard 100 mg |
| Full name | Voltaren Retard 100 mg, Dragées |
| Authorisation holder | Novartis Pharma Schweiz AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | M01AB05 |
| First authorisation | 01 May 1979 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Voltaren Retard 100 mg, Dragées | B | 01 May 1979 |
| 2 | Voltaren Retard 75 mg, Dragées | B | 24 April 1992 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 11 | 10 | Dragée(s) | M01AB05 | 07.10.1. | B |
| 38 | 30 | Dragée(s) | M01AB05 | 07.10.1. | B |
| 46 | 100 | Dragée(s) | M01AB05 | 07.10.1. | B |
| 54 | 20 | Dragée(s) | M01AB05 | 07.10.1. | B |
| 62 | 100 | Dragée(s) | M01AB05 | 07.10.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Voltaren Retard 100 mg authorised in Switzerland?
Yes. Voltaren Retard 100 mg is authorised by Swissmedic under authorisation number 41962, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Voltaren Retard 100 mg have?
Voltaren Retard 100 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Voltaren Retard 100 mg?
The authorisation holder is Novartis Pharma Schweiz AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.